Jane Street
ACXP icon

Jane Street’s Acurx Pharmaceuticals ACXP Stock Holding History

Jane Street’s Portfolio ACXP Stock Details ACXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$24.4K Sell
15,727
-38,915
-71% -$81K ﹤0.01% 11158
2026
Q1 		$203K Buy
54,642
+43,899
+409% +$125K ﹤0.01% 10122
2025
Q4 		$26.8K Buy
+10,743
New +$51.5K ﹤0.01% 10668
2025
Q3 		– Sell
-1,401
Closed -$14.3K – 10666
2025
Q2 		$14.3K Buy
+1,401
New +$11.3K ﹤0.01% 9387

Other funds holding ACXP

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
PFS
Prospect Financial Services Melville, New York $197M AUM 24.49% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
IWC
Integrated Wealth Concepts Waltham, Massachusetts $20.5B AUM 24.45% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $761M AUM 39.85% 1-Year Est. Return
NS
NBC Securities Birmingham, Alabama $1.48B AUM 31.07% 1-Year Est. Return

Jane Street's ACXP Position: Q2 2026 in Review

Jane Street reduced its Acurx Pharmaceuticals (ACXP) stake by 71% in Q2 2026, selling an estimated $81K and leaving 15,727 shares worth $24.4K. The position accounts for ﹤0.01% of the portfolio, ranked #11158.

Jane Street first reported a position in ACXP in Q2 2025 and has held it in 4 quarters since. The position peaked at $203K in Q1 2026. 19 funds tracked by Wall St. Rank hold ACXP as of Q2 2026.

  • Jane Street held 15,727 shares of Acurx Pharmaceuticals worth $24.4K as of Q2 2026.
  • Jane Street sold 38,915 Acurx Pharmaceuticals shares in Q2 2026, an estimated $81K.
  • Acurx Pharmaceuticals made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #11158 holding.
  • Jane Street first reported a position in Acurx Pharmaceuticals in Q2 2025 and has held it in 4 quarters since.
  • Jane Street's Acurx Pharmaceuticals position peaked at $203K in Q1 2026.
  • 19 funds tracked by Wall St. Rank held Acurx Pharmaceuticals as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.